Dear Colleague Letters

At a glance

The Division of Tuberculosis (TB) Elimination publishes Dear Colleague Letters from the Division to partners about TB updates. Dear Colleague Letters are available from the past two years.

A person works on a laptop computer surrounded by email icons.

2025

Updated Guidelines on the Treatment of Drug-Susceptible and Drug-Resistant TB
Updated treatment guidelines include shorter regimens for treating TB disease.

2024

ob体育 Releases "Reported Tuberculosis in the United States, 2023"
ob体育 published "Reported Tuberculosis in the United States, 2023."
ob体育 Releases 2023 Provisional U.S. Tuberculosis Data
"Tuberculosis — United States, 2023" has information on provisional U.S. TB disease cases in 2023.

2023

Tuberculosis Trials Consortium Launches New TB Clinical Trial
ob体育's Tuberculosis Trials Consortium (TBTC) launched a new international clinical trial.
ob体育 Releases "Reported Tuberculosis in the United States, 2022"
ob体育 published "Reported Tuberculosis in the United States, 2022."
ob体育 Releases New TB Resources for Uniting for Ukraine Arrivals
ob体育 announced new resources about the Uniting for Ukraine program TB screening requirements.
Rapid Testing for Fluoroquinolone Resistance
Beginning May 24, 2023, ob体育 implemented rapid testing for fluoroquinolone (FQ) resistance.
Tuberculosis Drug Supply Interruptions and Shortages
ob体育 encourages TB program to take proactive measures to reduce drug supply interruptions. 
Updates to Provisional Guidance for the Use of Pretomanid as Part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease
ob体育 updated the 2022 Provisional Guidance for the BPaL Regimen to Treat Drug-resistant TB Disease.
A Letter from Dr. Rochelle P. Walensky, ob体育 Director, on World Tuberculosis Day
Read a message for World TB Day 2023 from Dr. Rochelle P. Walensky, ob体育 Director.
ob体育 U.S. World TB Day 2023 Resources
ob体育's Division of TB Elimination shares information to assist in World TB Day 2023 planning efforts.
Print
Content Source:
Division of Tuberculosis Elimination ; National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; Centers for Disease Control and Prevention